• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酸脱氢酶突变是胃肠道间质瘤整体表观基因组差异的基础。

Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.

机构信息

National Cancer Institute-Center for Cancer Research, Bethesda, MD 20892-4265, USA.

出版信息

Cancer Discov. 2013 Jun;3(6):648-57. doi: 10.1158/2159-8290.CD-13-0092. Epub 2013 Apr 2.

DOI:10.1158/2159-8290.CD-13-0092
PMID:23550148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4135374/
Abstract

Gastrointestinal stromal tumors (GIST) harbor driver mutations of signal transduction kinases such as KIT, or, alternatively, manifest loss-of-function defects in the mitochondrial succinate dehydrogenase (SDH) complex, a component of the Krebs cycle and electron transport chain. We have uncovered a striking divergence between the DNA methylation profiles of SDH-deficient GIST (n = 24) versus KIT tyrosine kinase pathway-mutated GIST (n = 39). Infinium 450K methylation array analysis of formalin-fixed paraffin-embedded tissues disclosed an order of magnitude greater genomic hypermethylation relative to SDH-deficient GIST versus the KIT-mutant group (84.9 K vs. 8.4 K targets). Epigenomic divergence was further found among SDH-mutant paraganglioma/pheochromocytoma (n = 29), a developmentally distinct SDH-deficient tumor system. Comparison of SDH-mutant GIST with isocitrate dehydrogenase-mutant glioma, another Krebs cycle-defective tumor type, revealed comparable measures of global hypo- and hypermethylation. These data expose a vital connection between succinate metabolism and genomic DNA methylation during tumorigenesis, and generally implicate the mitochondrial Krebs cycle in nuclear epigenomic maintenance.

摘要

胃肠道间质瘤(GIST)具有信号转导激酶的驱动突变,如 KIT,或者表现为线粒体琥珀酸脱氢酶(SDH)复合物的功能丧失缺陷,SDH 复合物是三羧酸循环和电子传递链的一个组成部分。我们发现 SDH 缺陷型 GIST(n = 24)与 KIT 酪氨酸激酶通路突变型 GIST(n = 39)的 DNA 甲基化谱之间存在显著差异。福尔马林固定石蜡包埋组织的 Infinium 450K 甲基化阵列分析显示,相对于 KIT 突变组(84.9 K 个靶标),SDH 缺陷型 GIST 的基因组超甲基化程度高出一个数量级(84.9 K 个靶标)。在发育上不同的 SDH 缺陷型副神经节瘤/嗜铬细胞瘤(n = 29)中也发现了表观基因组的差异。将 SDH 突变型 GIST 与另一种三羧酸循环缺陷性肿瘤类型异柠檬酸脱氢酶突变型胶质瘤进行比较,发现全基因组低甲基化和高甲基化的程度相当。这些数据揭示了琥珀酸代谢与肿瘤发生过程中基因组 DNA 甲基化之间的重要联系,并普遍表明线粒体三羧酸循环参与核表观基因组的维持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/e04cddfe26ab/nihms612316f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/e92c16638346/nihms612316f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/a240daa8c078/nihms612316f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/0128242ffc8b/nihms612316f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/e04cddfe26ab/nihms612316f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/e92c16638346/nihms612316f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/a240daa8c078/nihms612316f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/0128242ffc8b/nihms612316f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6483/4135374/e04cddfe26ab/nihms612316f4.jpg

相似文献

1
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.琥珀酸脱氢酶突变是胃肠道间质瘤整体表观基因组差异的基础。
Cancer Discov. 2013 Jun;3(6):648-57. doi: 10.1158/2159-8290.CD-13-0092. Epub 2013 Apr 2.
2
Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.琥珀酸脱氢酶缺陷与胃肠道间质瘤中 5-羟甲基胞嘧啶生成减少有关:对肿瘤发生机制的影响。
Mod Pathol. 2013 Nov;26(11):1492-7. doi: 10.1038/modpathol.2013.86. Epub 2013 Jun 7.
3
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.琥珀酸脱氢酶缺陷在缺乏 KIT 和 PDGFRA 突变的胃肠间质瘤中。
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8. doi: 10.1073/pnas.1009199108. Epub 2010 Dec 20.
4
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.KIT/PDGFRA 野生型胃肠道间质瘤的分子亚型:来自美国国立卫生研究院胃肠道间质瘤临床中心的报告。
JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
5
Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.琥珀酸脱氢酶缺陷型胃肠道间质瘤的当前治疗策略。
Cancer Metastasis Rev. 2019 Sep;38(3):525-535. doi: 10.1007/s10555-019-09818-0.
6
Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.琥珀酸脱氢酶缺陷型胃肠道间质瘤(GISTs)——综述
Int J Biochem Cell Biol. 2014 Aug;53:514-9. doi: 10.1016/j.biocel.2014.05.033. Epub 2014 Jun 2.
7
KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.在一个幼稚的琥珀酸脱氢酶缺陷型胃 GIST 中存在 KIT 突变。
Genes Chromosomes Cancer. 2019 Nov;58(11):798-803. doi: 10.1002/gcc.22768. Epub 2019 Jun 10.
8
Germline Mutations in SDH-Deficient GISTs: A Current Update.SDH 缺陷型 GIST 中的胚系突变:最新研究进展。
Genes (Basel). 2023 Mar 4;14(3):646. doi: 10.3390/genes14030646.
9
A Review of Genomic Testing and SDH- Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST.胃肠道间质瘤的基因组检测与琥珀酸脱氢酶缺陷综述:深入了解胃肠道间质瘤
Cancer Med. 2025 Feb;14(3):e70669. doi: 10.1002/cam4.70669.
10
Preferential hypermethylation in SDH-deficient wild-type GIST.SDH 缺陷型野生型 GIST 的优先超甲基化。
J Clin Pathol. 2023 Dec 14;77(1):34-39. doi: 10.1136/jcp-2022-208462.

引用本文的文献

1
Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.油橄榄苦素作为一种多功能抗癌剂:作用机制见解、先进递送策略及精准肿瘤学中的协同作用
Int J Mol Sci. 2025 Jun 9;26(12):5521. doi: 10.3390/ijms26125521.
2
Molecular Biomarkers of Glioma.神经胶质瘤的分子生物标志物
Biomedicines. 2025 May 26;13(6):1298. doi: 10.3390/biomedicines13061298.
3
Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors.胃肠道间质瘤的全基因组DNA甲基化和拷贝数改变

本文引用的文献

1
Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.免疫组化检测到胃肠道间质瘤(GIST)中琥珀酸脱氢酶亚单位 A(SDHA)的缺失提示 SDHA 种系突变。
Am J Surg Pathol. 2013 Feb;37(2):234-40. doi: 10.1097/PAS.0b013e3182671178.
2
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.5-羟甲基胞嘧啶的缺失是黑色素瘤的一个表观遗传标志。
Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033.
3
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Genes Chromosomes Cancer. 2025 Mar;64(3):e70046. doi: 10.1002/gcc.70046.
4
Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer.微卫星稳定的BRAF突变型结直肠癌的综合代谢组学和表观基因组学特征分析
Oncogene. 2025 Mar 18. doi: 10.1038/s41388-025-03326-y.
5
Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies.琥珀酸脱氢酶缺陷型胃肠道间质瘤全身治疗的最新进展
Curr Treat Options Oncol. 2025 Apr;26(4):227-240. doi: 10.1007/s11864-025-01304-w. Epub 2025 Mar 6.
6
Current Drug Resistance Mechanisms and Treatment Options in Gastrointestinal Stromal Tumors: Summary and Update.胃肠道间质瘤的现有耐药机制和治疗选择:总结与更新。
Curr Treat Options Oncol. 2024 Nov;25(11):1390-1405. doi: 10.1007/s11864-024-01272-7. Epub 2024 Oct 23.
7
A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.一种用于临床相关SDHA变体功能分析的新型人类SDHA基因敲除细胞系模型
Clin Cancer Res. 2024 Dec 2;30(23):5399-5412. doi: 10.1158/1078-0432.CCR-24-1601.
8
Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance.三羧酸循环与非代谢过程的关系:一个关于 DNA 修复及其对癌症治疗耐药性影响的小故事。
Int J Mol Sci. 2024 Aug 21;25(16):9054. doi: 10.3390/ijms25169054.
9
Metabolic adaptations in prostate cancer.前列腺癌的代谢适应。
Br J Cancer. 2024 Nov;131(8):1250-1262. doi: 10.1038/s41416-024-02762-z. Epub 2024 Jul 5.
10
DNA methylation in human diseases.人类疾病中的DNA甲基化
Heliyon. 2024 Jun 4;10(11):e32366. doi: 10.1016/j.heliyon.2024.e32366. eCollection 2024 Jun 15.
富马酸盐和琥珀酸盐抑制依赖于 α-KG 的组蛋白和 DNA 去甲基酶,而这些物质在 FH 和 SDH 肿瘤抑制因子突变中积累。
Genes Dev. 2012 Jun 15;26(12):1326-38. doi: 10.1101/gad.191056.112. Epub 2012 Jun 7.
4
Genome-wide DNA methylation profiling using Infinium® assay.使用 Infinium® 分析进行全基因组 DNA 甲基化分析。
Epigenomics. 2009 Oct;1(1):177-200. doi: 10.2217/epi.09.14.
5
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.体细胞镶嵌性 IDH1 和 IDH2 突变与 Ollier 病和 Maffucci 综合征中的软骨瘤和梭形细胞血管瘤有关。
Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004.
6
A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology.雌激素受体阳性乳腺癌的甲基化偏离表型与恶性生物学相关。
Am J Pathol. 2011 Jul;179(1):55-65. doi: 10.1016/j.ajpath.2011.03.022. Epub 2011 May 13.
7
SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.通过大规模平行测序鉴定出 KIT-PDGFRA 野生型胃肠道间质瘤中的 SDHA 功能丧失突变。
J Natl Cancer Inst. 2011 Jun 22;103(12):983-7. doi: 10.1093/jnci/djr130. Epub 2011 Apr 19.
8
Inborn and acquired metabolic defects in cancer.癌症中的先天性和获得性代谢缺陷。
J Mol Med (Berl). 2011 Mar;89(3):213-20. doi: 10.1007/s00109-011-0728-4. Epub 2011 Feb 8.
9
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.琥珀酸脱氢酶缺陷在缺乏 KIT 和 PDGFRA 突变的胃肠间质瘤中。
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8. doi: 10.1073/pnas.1009199108. Epub 2010 Dec 20.
10
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.白血病 IDH1 和 IDH2 突变导致超甲基化表型,破坏 TET2 功能,并损害造血分化。
Cancer Cell. 2010 Dec 14;18(6):553-67. doi: 10.1016/j.ccr.2010.11.015. Epub 2010 Dec 9.